Malignancy Risks Associated with Endometriosis: Epidemiology

While non-malignant, endometriosis shares similar features with cancer. Several epidemiologic studies were conducted in an attempt to quantify cancer risk in endometriosis patients. The results from a meta-analysis of studies on the associations between endometriosis and cancer published up to 2019 are presented and discussed. The chapter also considers the methodologic complexities inherent to this area of research and their impact on interpretation of the findings. The potential mechanisms underlying these associations are also discussed, along with recommendations for information to patients, cancer screening, and long-term management of endometriosis patients with regards to their cancer risk. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others Change history 10 September 2022 Correction to:

Missmer SA. Commentary: endometriosis--epidemiologic considerations for a potentially 'high-risk' population. Int J Epidemiol. 2009;38(4):1154–5. Mc CK, Froats ER, Falk HC. Epidermoid carcinoma arising in an endometrial cyst of the ovary. Arch Pathol (Chic). 1946;41:335–7. Garry R. Endometriosis: an invasive disease. Gynecol Endoscop. 2001;10:79–82. Zondervan KT, et al. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9. Shafrir AL, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018;51:1–15. Kvaskoff M, et al. Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update. 2015;21(4):500–16. Kvaskoff M, et al. Endometriosis and cancer: a systematic review and meta-analysis. Hum Reprod Update. 2020;27:393. Sterne JA, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. Saavalainen L, et al. Risk of gynecologic cancer according to the type of endometriosis. Obstet Gynecol. 2018;131(6):1095–102. Buis CC, et al. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod. 2013;28:3358. Kobayashi H, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007;17(1):37–43. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–56. Vaughan S, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719–25. Dunselman GA, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12. Lac V, et al. Iatrogenic endometriosis harbors somatic cancer-driver mutations. Hum Reprod. 2019;34(1):69–78. Lac V, et al. Oncogenic mutations in histologically normal endometrium: the new normal? J Pathol. 2019;249(2):173–81. Ruderman R, Pavone ME. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects. Minerva Ginecol. 2017;69(3):286–94. Anglesio MS, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376(19):1835–48. Farland LV, et al. Laparoscopically confirmed endometriosis and breast cancer in the Nurses' Health Study II. Obstet Gynecol. 2016;128(5):1025–31. Mogensen JB, et al. Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol. 2016;143(1):87–92. Mavaddat N, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104(1):21–34. Glynn RJ, et al. Comparison of questionnaire-based breast cancer prediction models in the Nurses' Health Study. Cancer Epidemiol Biomark Prev. 2019;28(7):1187–94. Brinton LA, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomark Prev. 2005;14(12):2929–35. Farland LV, et al. Endometriosis and the risk of skin cancer: a prospective cohort study. Cancer Causes Control. 2017;28:1011. Saavalainen L, et al. A Nationwide Cohort Study on the risk of non-gynecological cancers in women with surgically verified endometriosis. Int J Cancer. 2018;143:2725. Li J, et al. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis. Arch Gynecol Obstet. 2019;299(1):35–46. Gandini S, et al. The risk of extra-ovarian malignancies among women with endometriosis: a systematic literature review and meta-analysis. Crit Rev Oncol Hematol. 2019;134:72–81. Nnoaham KE, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96:366. Ghiasi M, Kulkarni MT, Missmer SA. Is endometriosis more common and more severe than it was 30 years ago? J Minim Invasive Gynecol. 2020;27(2):452–61. Missmer SA. Why so null? Methodologic necessities to advance endometriosis discovery. Paediatr Perinat Epidemiol. 2019;33(1):26–7. Lee AW, et al. Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril. 2016;105(1):35–43 e1-10. Lu Y, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet. 2015;24(20):5955–64. Painter JN, et al. Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Med. 2018;7(5):1978–87. National Cancer Institute. SEER cancer statistics review (CSR) 1975–2014. 2017; Available from: https://seer.cancer.gov/csr/1975_2014 (accessed June 26, 2017). Kvaskoff M, Horne AW, Missmer SA. Informing women with endometriosis about ovarian cancer risk. Lancet. 2017;390(10111):2433–4. American Cancer Society. American Cancer Society Guidelines for the Early Detection of Cancer: Cancer Screening Guidelines | Detecting Cancer Early. 2018 15 September 2020];. Available from: www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/american-cancer-society-guidelines-forthe-early-detection-of-cancer.html. Buys SS, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295–303. Jacobs IJ, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945–56. Mallen A, et al. Surgical prevention strategies in ovarian cancer. Gynecol Oncol. 2018;151(1):166–75. Berek JS, et al. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol. 2010;116(3):733–43. Parker WH, et al. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond). 2009;5(5):565–76. Atsma F, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13(2):265–79. Rocca WA, et al. Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based Cohort Study. Mayo Clin Proc. 2016;91(11):1577–89. Chen X, Guo T, Li B. Influence of prophylactic oophorectomy on mood and sexual function in women of menopausal transition or postmenopausal period. Arch Gynecol Obstet. 2013;288(5):1101–6. Melton LJ 3rd, et al. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res. 2003;18(5):900–5. Parker WH. Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health. J Minim Invasive Gynecol. 2010;17(2):161–6. Manchanda R, et al. Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. Gynecol Oncol. 2015;139(3):487–94. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Kvaskoff, M., Missmer, S.A. (2022). Malignancy Risks Associated with Endometriosis: Epidemiology. In: Oral, E. (eds) Endometriosis and Adenomyosis. Springer, Cham. https://doi.org/10.1007/978-3-030-97236-3_23 Download citation DOI: https://doi.org/10.1007/978-3-030-97236-3_23 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-97235-6 Online ISBN: 978-3-030-97236-3 eBook Packages: MedicineMedicine (R0)